Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007
Blood inflammatory phenotypes of asthma in the Constances cohort Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Clinical and immunological criteria of asthma control in pregnancy Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013
Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011
The autoimmune criteria of sarcoidosis Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020
Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Peripheral blood leukocyte immune responses are distinctly altered in sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 Year: 2018
Blood mitochondrial DNA as a biomarker of clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 56 (5) 2001769; 10.1183/13993003.01769-2020 Year: 2020
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016
Neutrophilic inflammation in sputum does not define a clinical distinct asthma phenotype in ATLANTIS Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021
Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011
Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001